Coreg. Buy more. Save more.

Flamel Technologies (Nasdaq: FLML) announced today that a payment
of $500,000 has been triggered in connection with the license
agreement it signed in 2007 with Wyeth Pharmaceuticals, a division of
Wyeth (NYSE: WYE). The agreement is for the development of a marketed
protein to be delivered using Flamel’s Medusa technology. …